nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.11.2013 | Original Paper

Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion

verfasst von: Susanne Jaeger, Carmen Pfiffner, Prisca Weiser, Gerhard Längle, Daniela Croissant, Wiltrud Schepp, Reinhold Kilian, Thomas Becker, Gerhard Eschweiler, Tilman Steinert

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to examine the long-term influence of involuntary hospitalization on medication adherence, engagement in out-patient treatment and perceived coercion to treatment participation.

Methods

In a naturalistic observational multi-centre study, 290 voluntarily and 84 involuntarily hospitalized patients with schizophrenia or schizoaffective disorder had been followed up over a period of 2 years with half-yearly assessments. Assessments included self-rated medication adherence, externally judged medication adherence by blood levels, engagement in treatment and perceived coercion. The statistical analyses were based on multilevel hierarchical modelling of longitudinal data. Level and development of the outcome was controlled for involuntariness, for sociodemographic characteristics and clinical history.

Results

Involuntariness of the index-hospitalization did not have an effect on the development of treatment engagement or medication adherence judged by blood levels in the course of the follow-up period when the models were controlled for sociodemographic variables and clinical history. It was associated, though, with a continuously lower self-rated medication adherence. Moreover, former involuntarily hospitalized patients more often felt coerced in several treatment aspects at the follow-up assessments. Yet, there was no difference between the voluntary and involuntary group with regard to the development of the levels of adherence or coercion experiences over time.

Conclusions

Involuntary hospitalization does not seem to impair future treatment engagement in patients with schizophrenia, but formerly involuntarily hospitalized patients continue to be more sensitive to subjective or real coercion in their treatment and more vulnerable to medication non-adherence. Hereby, their risk of future involuntary hospitalization might be increased.

Steinert T, Lepping P (2009) Legal provisions and practice in the management of violent patients. A case vignette study in 16 European countries. Eur Psychiatry 24:135–141PubMedCrossRef

Zinkler M, Priebe S (2002) Detention of the mentally ill in Europe-a review. Acta Psychiatr Scand 106:3–8PubMedCrossRef

Salize HJ, Dressing H (2004) Epidemiology of involuntary placement of mentally ill people across the European Union. Br J Psychiatry 184:163–168PubMedCrossRef

Dressing H, Salize HJ (2004) Compulsory admission of mentally ill patients in European Union Member States. Soc Psychiatry Psychiatr Epidemiol 39:797–803PubMed

Sanguineti VR, Samuel SE, Schwartz SL, Robeson MR (1996) Retrospective study of 2,200 involuntary psychiatric admissions and readmissions. Am J Psychiatry 153:392–396PubMed

Bruns G (1991) Zwangseinweisungspatienten—eine psychiatrische Risikogruppe. Nervenarzt 62:308–312PubMed

Szmukler GI, Bird AS, Button EJ (1981) Compulsory admission in a London borough: I. Social and clinical features and a follow-up. Psychol Med 11:617–636PubMedCrossRef

McEvoy JP, Applebaum PS, Apperson J, Geller JL, Freter S (1989) Why must some schizophrenic patients be involuntarily committed? The role of insight. Compr Psychiatry 30:13–17PubMedCrossRef

Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA (2009) Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophrenia Bull 35:336–346CrossRef

10.

Priebe S, Katsakou C, Amos T, Leese M, Morriss R, Rose D, Wykes T, Yeeles K (2009) Patients’ views and readmissions 1 year after involuntary hospitalisation. Br J Psychiatry 194:49–54PubMedCrossRef

11.

O’Donoghue B, Lyne J, Hill M, Larkin C, Feeney L, O’Callaghan E (2010) Involuntary admission from the patients’ perspective. Soc Psychiatry Psychiatr Epidemiol 45:631–638PubMedCrossRef

12.

Oluwatayo O, Gater R (2004) The role of engagement with services in compulsory admission of African/Caribbean patients. Soc Psychiatry Psychiatr Epidemiol 39:739–743PubMedCrossRef

13.

Munk-Jørgensen P, Mortensen PB, Machón RA (1991) Hospitalization patterns in schizophrenia. A 13-year follow-up. Schizophr Res 4:1–9PubMedCrossRef

14.

Fennig S, Rabinowitz J, Fennig S (1999) Involuntary first admission of patients with schizophrenia as a predictor of future admissions. Psychiatr Serv 50:1049–1052PubMed

15.

Van der Post LF, Peen J, Visch I, Mulder CL, Beekman AT, Dekker JJ (2013) Patient perspectives and the risk of compulsory admission: the Amsterdam study of acute psychiatry V. Int J Soc Psychiatry. doi:10.1177/0020764012470234 (epub ahead of print)

16.

Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54:49–55PubMedCrossRef

17.

Kallert TW, Glöckner M, Schützwohl M (2008) Involuntary vs. voluntary hospital admission. A systematic literature review on outcome diversity. Eur Arch Psychiatry Clin Neurosci 258:195–209PubMedCrossRef

18.

Opjordsmoen S, Friis S, Melle I, Haahr U, Johannessen JO, Larsen TK, Røssberg JI, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2010) A 2-year follow-up of involuntary admission’s influence upon adherence and outcome in first-episode psychosis. Acta Psychiatr Scand 121:371–376PubMedCrossRef

19.

Kilian R, Steinert T, Schepp W, Weiser P, Jaeger S, Pfiffner C, Frasch K, Eschweiler GW, Messer T, Croissant D, Becker T, Längle G (2012) Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. Eur Arch Psychiatry Clin Neurosci 262:589–598PubMedCrossRef

20.

Längle G, Steinert T, Weiser P, Bayer W, Jaeger S, Pfiffner C, Frasch K, Eschweiler G, Messer T, Croissant D, Becker T, Kilian R (2012) Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment. Acta Psychiatr Scand 125:372–381PubMedCrossRef

21.

Frasch K, Weiser P, Becker T, Längle G, Steinert T, Niederreiner C, Pfiffner C, Jäger S, Bayer W, Eschweiler GW, Kilian R (2012) Psychotropic drug treatment, clinical characteristics and cognitive processing speed in patients with schizophrenia: results from the ELAN study. Pharmacopsychiatry 45:138–145PubMedCrossRef

22.

Jaeger S, Pfiffner C, Weiser P, Kilian R, Becker T, Längle G, Eschweiler GW, Croissant D, Schepp W, Steinert T (2012) Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study. Psychiatry Res 200:83–88PubMedCrossRef

23.

Kay SR, Opler LA, Lindemeyer JP (1998) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 155:59–65

24.

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. DSM-IV-TR. 4th Edition, Text revision. American Psychiatric Association, Washington, DC

25.

Jaeger S, Gebhardt RP, Pfiffner C, Bayer W, Weiser P, Wiesner H, Steinert T (2009) Akzeptanz und Umsetzung von Empfehlungen zur Rückfallverhütung–Entwicklung der Compliance Selbst-Rating Instrumente CSRI-E und CSRI-K. In: Schneider F, Grözinger M (eds) Psychische Erkrankungen in der Lebensspanne–Abstractband zum DGPPN Kongress 2009 in Berlin. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Berlin

26.

Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 42:241–247PubMedCrossRef

27.

Muthén B, Asparouhov T (2011) Beyond multilevel regression modeling: Multilevel analysis in a general latent variable framework. In: Hox JJ, Roberts JK (eds) Handbook of advanced multilevel analysis. Taylor and Francis, New York, pp 15–40

28.

Muthén LK, Muthen BO (1998–2010) Mplus user’s guide. Sixth edition. Muthén & Muthén, Los Angeles, CA

29.

Pieters V (2003) Macht—Zwang—Sinn Subjektives Erleben, Behandlungsbewertungen und Therapieerfolge bei gerichtlichen Unterbringungen schizophrener Patienten. Psychiatrie-Verlag, Bonn

30.

Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, van Os J (2000) Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 102:203–210PubMedCrossRef

31.

Leung PK, Faulkner LR, McFarland BH, Riley C (1993) Indochinese patients in the civil commitment process. Bull Am Acad Psychiatry Law 21:81–89PubMed

32.

De Haan L, van Amelsvoort T, Dingemans P, Linszen D (2007) Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective 5 year follow-up. Pharmacopsychiatry 40:264–268PubMedCrossRef

33.

Kortrijk HE, Staring AB, van Baars AW, Mulder CL (2010) Involuntary admission may support treatment outcome and motivation in patients receiving assertive community treatment. Soc Psychiatry Psychiatr Epidemiol 45:245–252PubMedCrossRef

34.

Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D (2008) A large-scale validation study of the medication adherence rating scale (MARS). Schizophr Res 100:53–59PubMedCrossRef

35.

Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, Rush AJ (2007) Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv 58:817–844CrossRef

36.

Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32:724–742PubMedCrossRef

37.

Wright EC (1993) Non-compliance–or how many aunts has Matilda? Lancet 342:909–913PubMedCrossRef

38.

Fenton WS, Blyler CR, Heinssen RK (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 23:637–651PubMedCrossRef

39.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892–909PubMedCrossRef

40.

Day JC (2003) How reflections on concordance in mental health can affect research and clinical practice in adherence. Pharm J 271:505–507

41.

Fleischhacker WW, Oehl MA, Hummer M (2003) Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 64(Suppl):S10–S13

42.

Perkins DO (2002) Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63:1121–1128PubMedCrossRef

43.

Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ (2012) Medication adherence in schizophrenia. World J Psychiatr 2:74–82CrossRef

44.

Krivoy A, Fischel T, Zahalka H, Shoval G, Weizman A, Valevski A (2012) Outcomes of compulsorily admitted schizophrenia patients who agreed or disagreed to prolong their hospitalization. Compr Psychiatry 53:995–999PubMedCrossRef

45.

Nitzan U, Bukobza G, Aviram S, Fennig S, Lev-Ran S, Braw Y, Bloch Y (2013) Rebelliousness in patients suffering from schizophrenia-spectrum disorders. A possible predictor of attitudes towards medication. Psychiatry Res. doi:10.1016/j.psychres.2012.12.028 (epub ahead of print)PubMed

46.

Rain SD, Williams VF, Robbins PC, Monahan J, Steadman HJ, Vesselinov R (2003) Perceived coercion at hospital admission and adherence to mental health treatment after discharge. Psychiatr Serv 54:103–105PubMedCrossRef

47.

Bindman J, Reid Y, Szmukler G, Tiller J, Thornicroft G, Leese M (2005) Perceived coercion at admission to psychiatric hospital and engagement with follow-up–a cohort study. Soc Psychiatry Psychiatr Epidemiol 40:160–166PubMedCrossRef

Titel: Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion
verfasst von: Susanne Jaeger
Carmen Pfiffner
Prisca Weiser
Gerhard Längle
Daniela Croissant
Wiltrud Schepp
Reinhold Kilian
Thomas Becker
Gerhard Eschweiler
Tilman Steinert
Publikationsdatum: 01.11.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 11/2013
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-013-0687-x

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion